Phase 2 Peripheral Arterial Disease Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Peripheral Arterial DiseaseCoronary Artery Disease (CAD)
Sirius Therapeutics Co., Ltd.104 enrolled1 locationNCT07318155
Recruiting
Phase 2
Fisetin to Reduce Senescence and Mobility Impairment in PAD
ClaudicationPeripheral Arterial DiseaseAging+2 more
Northwestern University34 enrolled1 locationNCT06399809
Recruiting
Phase 1Phase 2
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
Peripheral Arterial Disease
Shahid Baba144 enrolled3 locationsNCT06480760
Recruiting
Phase 2
Passive Stretching in Peripheral Arterial Disease Patients
Peripheral Arterial DiseaseInflammationWalking, Difficulty
University of Wisconsin, La Crosse64 enrolled1 locationNCT06420752
Recruiting
Phase 1Phase 2
Carnosine for Peripheral Arterial Disease Patients
Peripheral Arterial Disease
Shahid Baba20 enrolled1 locationNCT05371145
Recruiting
Phase 2
The STAR-PAD trial is testing a new treatment for Peripheral Arterial Disease (PAD).
Peripheral Arterial Disease
North Sydney Local Health District100 enrolled3 locationsACTRN12619000423112